Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Xenotransplant News

Xenotransplant News US Food and Drug Administration guidance for industry on xenotransplantation The final version (for implementation) of the document, Guidance for Industry: Source Animal, Product, Preclinical, and Clinical Issues Concerning the Use of Xenotransplantation Products in Humans (first published on February 7, 2001), was published in the Federal Register of April 4, 2003, and is available on the Internet at http://www.fda.gov/cber/guidelines.htmclinxeno . In addition to matters relating to source animals and xenotransplantation, it includes guidance on human body fluids, cells, tissues or organs that have had contact with live animal cells, tissues or organs. UK survey on xenotransplantation * According to a report in Progress in Transplantation , a survey of potential heart and heart‐lung recipients and their caregivers revealed a lack of information and uncertainty about xenotransplantation. Approximately 80% of the 59 patients and 54 caregivers claimed that they had received little information about the topic. Most, however, were in favor of using animals for human benefit. PPL Therapeutics regenerative medicine assets transferred to consortium * The University of Pittsburgh Medical Center (UPMC) and other investors have formed Regenecor Holdings, Inc., to which PPL Therapeutics, Inc., has transferred all of its regenerative medicine business assets and associated intellectual http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Xenotransplantation Wiley

Xenotransplant News

Xenotransplantation , Volume 10 (4) – Jul 1, 2003
Download PDF
2 pages

Loading next page...
 
/lp/wiley/xenotransplant-news-ta76VhRGcf

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wiley
Copyright
Copyright © 2003 Wiley Subscription Services, Inc., A Wiley Company
ISSN
0908-665X
eISSN
1399-3089
DOI
10.1034/j.1399-3089.2003.00088.x
Publisher site
See Article on Publisher Site

Abstract

US Food and Drug Administration guidance for industry on xenotransplantation The final version (for implementation) of the document, Guidance for Industry: Source Animal, Product, Preclinical, and Clinical Issues Concerning the Use of Xenotransplantation Products in Humans (first published on February 7, 2001), was published in the Federal Register of April 4, 2003, and is available on the Internet at http://www.fda.gov/cber/guidelines.htmclinxeno . In addition to matters relating to source animals and xenotransplantation, it includes guidance on human body fluids, cells, tissues or organs that have had contact with live animal cells, tissues or organs. UK survey on xenotransplantation * According to a report in Progress in Transplantation , a survey of potential heart and heart‐lung recipients and their caregivers revealed a lack of information and uncertainty about xenotransplantation. Approximately 80% of the 59 patients and 54 caregivers claimed that they had received little information about the topic. Most, however, were in favor of using animals for human benefit. PPL Therapeutics regenerative medicine assets transferred to consortium * The University of Pittsburgh Medical Center (UPMC) and other investors have formed Regenecor Holdings, Inc., to which PPL Therapeutics, Inc., has transferred all of its regenerative medicine business assets and associated intellectual

Journal

Xenotransplantation – Wiley

Published: Jul 1, 2003

There are no references for this article.